tact with inhaled antigen will induce acute and chronic inflammatory changes in lung, varying fram acute, neutrophil-rich interstitial and intra-alveoIar exudates, to granulomatous interstitial reactions and intemtitial fibrosis. This knowledge is emphasized by the work presented in this Conference by Drs. Richerson and Moore and their colleagues. For most of the studies involving anixnal models, however, it has been difficult to be precise about the immunopathologic events involved, because of the likelihood that both cellular and humoral immunoreactivities are present. Based upon a great deal of laboratory work, it seems clear that both humoral as wen as cell mediated immune reactions can induce puhnonary inflammatory reactions, either independently of one another, or synergisticany. This would be analogous to immune complex-induced glomerulonephritis in which both anaphylactic as well as immune complex mechanisms are operative and result in the hctional and morphologic features of glornerulonephritis.1
From our own experimental studies in which the role of defined immunologic mechanisms in lung injury have been probed, and using reasonably unambiguous a p preaches, it has been demonstrated in a reverse passive Arthus type model that the in oioo deposition in lung airways of immune complexes results in an acute, neutrophil-rich interstitial and intra-alveolar reactior~.~ The pulmonary damage seen in this model requires the participation of neutrophils, presumably through their delivery of hydrolytic enzymes that are inimical to substrates in structural elements (such as collagen, e h t h , basement membrane and others) in the tissue. It has recently been possible to reproduce this lung infiammatory reaction in experimental animals using preformed immune complexes that are instjIled mtratra~heally.~ HistologicaIly, these resulting reactions are rather similar to those described above, in that there is a d.i&lse interstitial and intra-alveolar accumulation of neutrophils and considerable intra-alveolar edema and hemorrhage. Not surprisingly, these reactions also are complement and neutrophildependent. The phlogistic nature of the complexes is directly related to their size and, probably more importantly, to their complement firring capacitie~.~ In antigen excess, as the complement fixing activity rapidly drops off (at antigen concentration > 3 times the point of equivalence), there is a concamitant fall-off in the ability of the complexes to cause vasopermeability changes in lung, an accumulation of neutrophils, and intra-alveolar hemorrhage. Whether the size of the complexes is related to their phlogistic potential is not currently known. While intratracheal instillation of preformed immune complexes does not d e c t any naturally occurring disease process, the use of these preformed complexes does permit a probing of potential immunopathologic mechanisms in a manner that has not been successful with the kidney or any other organ. In the many immunopathologic studies of experimental glomerulonephritis, the infusion of preformed immune complexes has failed to induce glomerulonephritis. Thus, our own studies of lung-induced injury by preformed immune complexes has the potential of defining, for the first time, those immune complexes that are phlogistic for tissues, and they should pennit a definition of the pathogenesis of the idlammatory reaction induced in lung.
The continued injection of antigen into rabbits sensitized to bovine serum albumin has been shown by others to result in a diffuse interstitial pulmonary fibrosis with thickening of vascular (capillary) basement membrane and intramembranous deposition of immune ~omplexes.~ Both the manner in which these reactions have been induced, as well as the details of the imrnunopathology of these lesions are, in virtually every respect, identical with the earlier classic studies carried out in the kidney.5
These reactions are almost surely due to the deposition in tissues of large amounts of immune complexes, resulting in the triggering of a &ar inflammatory response that ultimately is associated with activation of interstitial fibroblasts and the deposition of large amounts of collagen. Thus, in studies using preformed immune complexes, the likelihood is high that, given the appropriate circumstances, pulmonary fibrosis should sooner or later ensue.
The role of immune complexes in the pathogenesis of human inflammatory lung diseases has been postulated in hypersensitivity pneumonitis where, initially, patients with farmer's lung or pigeon fancier's disease were found to have precipitating antibody in their sera.6 However, the subsequent lack of correlation between presence or absence of precipitating antibody in the serum and the presence or absence of pulmonary disease, and the demonstration of a better correlation of disease activity with lymphocyte reactivity ( blastogenesis ) to antigen have suggested that immune complexes may not be a proximate cause of the inflammatory changes in the lungs of patients with farmer's lung or pigeon fancier's disease.
Recently, sera from patients with idiopathic pulmonary fibrosis have been shown to contain a complement fixing factor that binds to the surfaces of RAJI lymphoc y t e~.~ This has been interpreted as evidence for the presence of immune complexes in the sera of these patients. In this Conference, evidence is presented that bronchial lavage fluids from the same patients yield a similar substance (putative immune complexes) as de-teded by Clq-binding assays. These data suggest that patients with idiopathic pubnonary fibrosis have immune complexes both in their lungs, as well as in their blood stream. The relevance of these observations to the underlying disease process is entirely unknown, but this a p pears to be the first dear-cut association between the presence of detectable immune complexes and lung disease in humans.
To what extent humoral and/or cellular mechanisms are responsible for the inflammatory diseases seen in humans is still largely unknown. The development of animal models to study fundamental reactions of lung to inflammatory mediators, together with the newly developing techniques for retrieval from the lung of soluble factors and cells, should provide the basis for an understanding of the pathogenesis of a large number of inflammatory lung diseases. 
